Filing Details
- Accession Number:
- 0001144204-14-062005
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-10-20 18:29:01
- Reporting Period:
- 2014-09-26
- Filing Date:
- 2014-10-20
- Accepted Time:
- 2014-10-20 17:29:01
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1379006 | Nanoviricides Inc. | NNVC | Services-Commercial Physical & Biological Research (8731) | 760674577 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1580568 | Milton Boniuk | C/O Nanoviricides, Inc. 135 Wood Street, Suite 205 West Haven CT 06516 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $0.001 | Acquisiton | 2014-09-26 | 3,167 | $3.20 | 662,130 | No | 4 | P | Direct | |
Common Stock, Par Value $0.001 | Acquisiton | 2014-09-29 | 15,841 | $3.20 | 677,921 | No | 4 | P | Direct | |
Common Stock, Par Value $0.001 | Acquisiton | 2014-09-30 | 19,300 | $3.16 | 697,271 | No | 4 | P | Direct | |
Common Stock, Par Value $0.001 | Acquisiton | 2014-09-30 | 30,300 | $3.00 | 727,571 | No | 4 | P | Direct | |
Common Stock, Par Value $0.001 | Acquisiton | 2014-09-30 | 11,692 | $3.15 | 739,263 | No | 4 | P | Direct | |
Common Stock, Par Value $0.001 | Acquisiton | 2014-10-01 | 1,200 | $3.10 | 740,463 | No | 4 | P | Direct | |
Common Stock, Par Value $0.001 | Acquisiton | 2014-10-01 | 18,500 | $3.10 | 758,963 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- Held by the Reporting Person and his wife. Does not include warrants to purchase an additional 542,856 shares of common stock held by the Reporting Person and his wife. Does not include: 190,477 shares of common stock held by the Boniuk Charitable Foundation; 314,286 shares of common stock and warrants to purchase 257,142 shares of common stock currently exercisable or an indeterminate number of shares of common stock issuable upon conversion of debentures held by Boniuk Interests Ltd.; or 952,381 shares of common stock issuable upon conversion of a 10% Coupon Series C Convertible Debenture or 187,000 shares of Series A Preferred Stock held by Milton Boniuk IRA, convertible into 654,500 shares of common stock, which are not readily convertible. Dr. Boniuk holds voting and dispositive power over the Boniuk Charitable Foundation, Boniuk Interests Ltd. and the Milton Boniuk IRA.